Published in PLoS Pathog on December 04, 2014
Plasmodium falciparum Histidine-Rich Protein II Compromises Brain Endothelial Barriers and May Promote Cerebral Malaria Pathogenesis. MBio (2016) 0.89
Activated Brain Endothelial Cells Cross-Present Malaria Antigen. PLoS Pathog (2015) 0.89
Mesenchymal stromal cell therapy attenuated lung and kidney injury but not brain damage in experimental cerebral malaria. Stem Cell Res Ther (2015) 0.82
Perivascular Arrest of CD8+ T Cells Is a Signature of Experimental Cerebral Malaria. PLoS Pathog (2015) 0.82
CD8+ T Cells Induce Fatal Brainstem Pathology during Cerebral Malaria via Luminal Antigen-Specific Engagement of Brain Vasculature. PLoS Pathog (2016) 0.79
Experimental Cerebral Malaria Spreads along the Rostral Migratory Stream. PLoS Pathog (2016) 0.79
Pathogenesis of cerebral malaria: new diagnostic tools, biomarkers, and therapeutic approaches. Front Cell Infect Microbiol (2015) 0.78
Activated Neutrophils Are Associated with Pediatric Cerebral Malaria Vasculopathy in Malawian Children. MBio (2016) 0.77
Chimeric Mice with Competent Hematopoietic Immunity Reproduce Key Features of Severe Lassa Fever. PLoS Pathog (2016) 0.77
The Immunologic Complexity of Growing Up with Malaria-Is Scientific Understanding Coming of Age? Clin Vaccine Immunol (2015) 0.76
Recent advances in microscopic techniques for visualizing leukocytes in vivo. F1000Res (2016) 0.76
Indocyanine Green Liposomes for Diagnosis and Therapeutic Monitoring of Cerebral Malaria. Theranostics (2016) 0.76
Endothelial-Leukocyte Interaction in Severe Malaria: Beyond the Brain. Mediators Inflamm (2015) 0.76
Progress in imaging methods: insights gained into Plasmodium biology. Nat Rev Microbiol (2016) 0.76
Severe malaria: what's new on the pathogenesis front? Int J Parasitol (2016) 0.75
ICAM-1 is a key receptor mediating cytoadherence and pathology in the Plasmodium chabaudi malaria model. Malar J (2017) 0.75
A quantitative brain map of experimental cerebral malaria pathology. PLoS Pathog (2017) 0.75
Myeloid expression of the AP-1 transcription factor JUNB modulates outcomes of type 1 and type 2 parasitic infections. Parasite Immunol (2015) 0.75
A Murine Model to Study Epilepsy and SUDEP Induced by Malaria Infection. Sci Rep (2017) 0.75
Exploring experimental cerebral malaria pathogenesis through the characterisation of host-derived plasma microparticle protein content. Sci Rep (2016) 0.75
Perforin Expression by CD8 T Cells Is Sufficient To Cause Fatal Brain Edema during Experimental Cerebral Malaria. Infect Immun (2017) 0.75
A Plasmodium yoelii HECT-like E3 ubiquitin ligase regulates parasite growth and virulence. Nat Commun (2017) 0.75
Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am J Pathol (1985) 7.14
A Plasmodium berghei reference line that constitutively expresses GFP at a high level throughout the complete life cycle. Mol Biochem Parasitol (2004) 5.80
Long-term, high-resolution imaging in the mouse neocortex through a chronic cranial window. Nat Protoc (2009) 5.68
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat Rev Drug Discov (2010) 5.55
Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J Clin Invest (2001) 5.05
Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell (1999) 5.01
Receptor-specific adhesion and clinical disease in Plasmodium falciparum. Am J Trop Med Hyg (1997) 3.92
A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain. Am J Pathol (1999) 3.72
The endothelial surface layer. Pflugers Arch (2000) 3.40
The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch (2007) 3.31
Human vascular endothelial cell adhesion receptors for Plasmodium falciparum-infected erythrocytes: roles for endothelial leukocyte adhesion molecule 1 and vascular cell adhesion molecule 1. J Exp Med (1992) 3.30
Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature (1998) 3.11
Neurological sequelae of cerebral malaria in children. Lancet (1990) 3.11
ICAM-1 signaling in endothelial cells. Pharmacol Rep (2009) 3.06
Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. Proc Natl Acad Sci U S A (1989) 3.03
Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability. J Biol Chem (2003) 2.98
Severe Plasmodium vivax malaria exhibits marked inflammatory imbalance. Malar J (2010) 2.88
L3T4+ T lymphocytes play a major role in the pathogenesis of murine cerebral malaria. J Immunol (1986) 2.79
Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration. Proc Natl Acad Sci U S A (2005) 2.71
Platelet accumulation in brain microvessels in fatal pediatric cerebral malaria. J Infect Dis (2003) 2.70
FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function. Am J Transplant (2004) 2.70
Intracranial pressure in African children with cerebral malaria. Lancet (1991) 2.67
Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. J Clin Invest (2009) 2.41
On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebral malaria. J Immunol (2002) 2.40
Human malarial disease: a consequence of inflammatory cytokine release. Malar J (2006) 2.36
Intravital observation of Plasmodium berghei sporozoite infection of the liver. PLoS Biol (2005) 2.32
A craniotomy surgery procedure for chronic brain imaging. J Vis Exp (2008) 2.24
Engagement of S1P₁-degradative mechanisms leads to vascular leak in mice. J Clin Invest (2011) 2.23
Perforin-dependent brain-infiltrating cytotoxic CD8+ T lymphocytes mediate experimental cerebral malaria pathogenesis. J Immunol (2003) 2.22
Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data. Immunol Rev (1989) 2.22
Rapid activation of endothelial cells enables Plasmodium falciparum adhesion to platelet-decorated von Willebrand factor strings. Blood (2009) 2.18
A reliable ex vivo invasion assay of human reticulocytes by Plasmodium vivax. Blood (2011) 2.17
A high frequency African coding polymorphism in the N-terminal domain of ICAM-1 predisposing to cerebral malaria in Kenya. Hum Mol Genet (1997) 2.17
Regulation of Weibel-Palade body exocytosis. Trends Cardiovasc Med (2005) 2.16
Immunopathogenesis of cerebral malaria. Int J Parasitol (2006) 2.08
Cerebral involvement in benign tertian malaria. Am J Trop Med Hyg (2002) 2.08
Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria. J Immunol (1996) 2.07
Cerebral malaria in inbred mice. I. A new model and its pathology. Trans R Soc Trop Med Hyg (1982) 2.06
Human cerebral malaria and the blood-brain barrier. Int J Parasitol (2006) 2.05
Cerebral malaria: the sequestration hypothesis. Parasitol Today (1994) 2.03
Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome. Pediatr Res (2010) 1.98
Angiopoietin-2 levels are associated with retinopathy and predict mortality in Malawian children with cerebral malaria: a retrospective case-control study*. Crit Care Med (2012) 1.97
Serum angiopoietin-1 and -2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children. PLoS One (2009) 1.93
Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans. Clin Microbiol Rev (2001) 1.91
Lethal malaria: Marchiafava and Bignami were right. J Infect Dis (2013) 1.88
Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease. Parasitology (2009) 1.87
Risk factors for persisting neurological and cognitive impairments following cerebral malaria. Arch Dis Child (2005) 1.85
Residual neurologic sequelae after childhood cerebral malaria. J Pediatr (1997) 1.84
Quantitative isolation and in vivo imaging of malaria parasite liver stages. Int J Parasitol (2006) 1.83
Malaria: mechanisms of erythrocytic infection and pathological correlates of severe disease. Annu Rev Pathol (2007) 1.83
The neuropathology of fatal cerebral malaria in malawian children. Am J Pathol (2011) 1.79
Immune surveillance by the liver. Nat Immunol (2013) 1.79
Molecular mechanisms of cytoadherence in malaria. Am J Physiol (1999) 1.77
The cytokine theory of human cerebral malaria. Parasitol Today (1994) 1.73
Retinal pathology of pediatric cerebral malaria in Malawi. PLoS One (2009) 1.71
Intracranial hypertension in Africans with cerebral malaria. Arch Dis Child (1997) 1.71
Production of erythropoietic cells in vitro for continuous culture of Plasmodium vivax. Int J Parasitol (2007) 1.70
Immunopathology of cerebral malaria: morphological evidence of parasite sequestration in murine brain microvasculature. Infect Immun (2000) 1.70
The smallest stroke: occlusion of one penetrating vessel leads to infarction and a cognitive deficit. Nat Neurosci (2012) 1.70
Involvement of IFN-gamma receptor-medicated signaling in pathology and anti-malarial immunity induced by Plasmodium berghei infection. Eur J Immunol (2000) 1.68
Release of hepatic Plasmodium yoelii merozoites into the pulmonary microvasculature. PLoS Pathog (2007) 1.67
A role for natural regulatory T cells in the pathogenesis of experimental cerebral malaria. Am J Pathol (2007) 1.67
Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function. J Clin Invest (2006) 1.67
Magnetic resonance imaging of the brain in patients with cerebral malaria. Clin Infect Dis (1995) 1.65
Immune-mediated mechanisms of parasite tissue sequestration during experimental cerebral malaria. J Immunol (2010) 1.65
Cytoadherence and sequestration in Plasmodium falciparum: defining the ties that bind. Microbes Infect (2003) 1.65
Role of sphingosine-1 phosphate in the enhancement of endothelial barrier integrity by platelet-released products. Am J Physiol Lung Cell Mol Physiol (2003) 1.64
Acute brain MRI findings in 120 Malawian children with cerebral malaria: new insights into an ancient disease. AJNR Am J Neuroradiol (2012) 1.64
Specific receptor usage in Plasmodium falciparum cytoadherence is associated with disease outcome. PLoS One (2011) 1.62
IP-10-mediated T cell homing promotes cerebral inflammation over splenic immunity to malaria infection. PLoS Pathog (2009) 1.61
Mouse models of blood-stage malaria infections: immune responses and cytokines involved in protection and pathology. Chem Immunol (2002) 1.61
Pulmonary manifestations of uncomplicated falciparum and vivax malaria: cough, small airways obstruction, impaired gas transfer, and increased pulmonary phagocytic activity. J Infect Dis (2002) 1.60
Whole blood angiopoietin-1 and -2 levels discriminate cerebral and severe (non-cerebral) malaria from uncomplicated malaria. Malar J (2009) 1.59
Volume flow and wall shear stress quantification in the human conjunctival capillaries and post-capillary venules in vivo. Biorheology (2007) 1.58
Platelets reorient Plasmodium falciparum-infected erythrocyte cytoadhesion to activated endothelial cells. J Infect Dis (2004) 1.57
TNF-induced microvascular pathology: active role for platelets and importance of the LFA-1/ICAM-1 interaction. Eur Cytokine Netw (1994) 1.56
Ultrasound findings in Plasmodium falciparum malaria: a pilot study. Pediatr Crit Care Med (2011) 1.56
Sphingosine 1-phosphate (S1P): Physiology and the effects of S1P receptor modulation. Neurology (2011) 1.56
Perivascular spaces and the two steps to neuroinflammation. J Neuropathol Exp Neurol (2008) 1.52
Murine cerebral malaria is associated with a vasospasm-like microcirculatory dysfunction, and survival upon rescue treatment is markedly increased by nimodipine. Am J Pathol (2010) 1.51
Platelets potentiate brain endothelial alterations induced by Plasmodium falciparum. Infect Immun (2006) 1.51
Experimental models of cerebral malaria. Curr Top Microbiol Immunol (2005) 1.50
A requirement for microglial TLR4 in leukocyte recruitment into brain in response to lipopolysaccharide. J Immunol (2006) 1.49
CD8+ T cells and IFN-γ mediate the time-dependent accumulation of infected red blood cells in deep organs during experimental cerebral malaria. PLoS One (2011) 1.47
Accumulation of Plasmodium berghei-infected red blood cells in the brain is crucial for the development of cerebral malaria in mice. Infect Immun (2010) 1.47
Granzyme B expression by CD8+ T cells is required for the development of experimental cerebral malaria. J Immunol (2011) 1.46
Pathogenic T cells in cerebral malaria. Int J Parasitol (2006) 1.45
Depletion of CD4+ or CD8+ T-cells prevents Plasmodium berghei induced cerebral malaria in end-stage disease. Parasitology (1997) 1.45
Imaging experimental cerebral malaria in vivo: significant role of ischemic brain edema. J Neurosci (2005) 1.45
The role of ICAM-1 in Plasmodium falciparum cytoadherence. Eur J Cell Biol (2005) 1.45
Late administration of monoclonal antibody to leukocyte function-antigen 1 abrogates incipient murine cerebral malaria. Eur J Immunol (1991) 1.42
Development of SHIRPA to characterise the phenotype of gene-targeted mice. Behav Brain Res (2001) 1.42
Mannose receptor expression specifically reveals perivascular macrophages in normal, injured, and diseased mouse brain. Glia (2005) 1.42
Sudden increase in virulence in a strain of Plasmodium berghei yoelii. Ann Trop Med Parasitol (1975) 1.41
Redefining cerebral malaria by including malaria retinopathy. Future Microbiol (2011) 1.40
Brain capillary blockage produced by a virulent strain of rodent malaria. Science (1974) 1.40
Brain sphingosine-1-phosphate receptors: implication for FTY720 in the treatment of multiple sclerosis. Pharmacol Ther (2007) 1.40
C5 deficiency and C5a or C5aR blockade protects against cerebral malaria. J Exp Med (2008) 1.38
Cerebral malaria caused by Plasmodium vivax in adult subjects. Indian J Crit Care Med (2008) 1.38